US Stock MarketDetailed Quotes

CRXTW CLARUS THERAPEUTICS HLDGS INC

Watchlist
  • 0.000
  • 0.0000.00%
Close Mar 28 09:30 ET
0Market Cap0.00P/E (TTM)

CLARUS THERAPEUTICS HLDGS INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Total revenue
45.74%4.05M
72.15%4.01M
119.14%13.96M
88.05%4.56M
92.72%4.29M
2.78M
2.33M
6.37M
2.43M
2.22M
Operating revenue
45.74%4.05M
72.15%4.01M
119.14%13.96M
88.05%4.56M
92.72%4.29M
--2.78M
--2.33M
--6.37M
--2.43M
--2.22M
Cost of revenue
109.39%1.16M
80.93%664K
-68.69%2.72M
259.05%1.29M
98.44%510K
554K
367K
8.69M
359K
257K
Gross profit
29.89%2.89M
70.50%3.35M
584.77%11.24M
58.35%3.27M
91.97%3.78M
2.23M
1.96M
-2.32M
2.07M
1.97M
Operating expense
-12.42%13.54M
32.49%16.9M
13.62%50.97M
3.13%10.54M
-7.58%12.21M
15.46M
12.75M
44.86M
10.22M
13.21M
Selling and administrative expenses
-17.12%12.31M
38.75%16.01M
11.49%47.34M
-5.99%10.01M
-7.13%10.93M
--14.86M
--11.54M
--42.46M
--10.64M
--11.77M
-Selling and marketing expense
-29.82%6.69M
35.18%10.73M
0.50%30.68M
-18.76%5.66M
-13.55%7.55M
--9.53M
--7.94M
--30.52M
--6.97M
--8.73M
-General and administrative expense
5.59%5.63M
46.60%5.29M
39.58%16.66M
18.23%4.35M
11.32%3.38M
--5.33M
--3.61M
--11.94M
--3.68M
--3.04M
Research and development costs
102.81%1.23M
-27.19%881K
51.38%3.63M
227.86%537K
-11.27%1.28M
--606K
--1.21M
--2.4M
---420K
--1.44M
Operating profit
19.53%-10.65M
-25.57%-13.55M
15.78%-39.73M
10.86%-7.27M
24.99%-8.43M
-13.24M
-10.79M
-47.18M
-8.16M
-11.24M
Net non-operating interest income expense
58.58%-2.02M
57.67%-1.96M
-3.41%-15.89M
58.07%-1.93M
-3.64%-4.45M
-4.88M
-4.64M
-15.37M
-4.6M
-4.29M
Non-operating interest income
--0
--1K
-92.00%2K
0.00%1K
0.00%1K
--0
--0
--25K
--1K
--1K
Non-operating interest expense
-58.58%2.02M
-57.65%1.97M
3.25%15.9M
-58.06%1.93M
3.64%4.45M
--4.88M
--4.64M
--15.39M
--4.6M
--4.29M
Other net income (expense)
1.98M
642K
-77.56%15.01M
-62.43%4.9M
-51.72%10.11M
66.89M
13.04M
20.94M
Gain on sale of security
--728K
--642K
-81.30%12.51M
-62.43%4.9M
-63.66%7.61M
----
----
--66.89M
--13.04M
--20.94M
Special income (charges)
--1.25M
----
--2.5M
--0
--2.5M
--0
----
--0
--0
--0
-Less:Other special charges
---1.25M
----
---2.5M
--0
---2.5M
----
----
----
----
----
Income before tax
40.97%-10.69M
3.62%-14.87M
-1,034.80%-40.62M
-1,647.48%-4.3M
-151.22%-2.77M
-18.12M
-15.43M
4.35M
278K
5.41M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
40.97%-10.69M
3.62%-14.87M
-1,034.80%-40.62M
-1,647.48%-4.3M
-151.22%-2.77M
-18.12M
-15.43M
4.35M
278K
5.41M
Net income continuous Operations
40.97%-10.69M
3.62%-14.87M
-1,034.80%-40.62M
-1,647.48%-4.3M
-151.22%-2.77M
---18.12M
---15.43M
--4.35M
--278K
--5.41M
Minority interest income
Net income attributable to the parent company
40.97%-10.69M
3.62%-14.87M
-1,034.80%-40.62M
-1,647.48%-4.3M
-151.22%-2.77M
-18.12M
-15.43M
4.35M
278K
5.41M
Preferred stock dividends
Other preferred stock dividends
0
0
-102.81%-412K
3.8M
3.94M
14.68M
Net income attributable to common stockholders
51.20%-10.69M
23.22%-14.87M
-288.94%-40.21M
72.99%-3.89M
-151.22%-2.77M
-21.91M
-19.37M
-10.34M
-14.4M
5.41M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Total revenue 45.74%4.05M72.15%4.01M119.14%13.96M88.05%4.56M92.72%4.29M2.78M2.33M6.37M2.43M2.22M
Operating revenue 45.74%4.05M72.15%4.01M119.14%13.96M88.05%4.56M92.72%4.29M--2.78M--2.33M--6.37M--2.43M--2.22M
Cost of revenue 109.39%1.16M80.93%664K-68.69%2.72M259.05%1.29M98.44%510K554K367K8.69M359K257K
Gross profit 29.89%2.89M70.50%3.35M584.77%11.24M58.35%3.27M91.97%3.78M2.23M1.96M-2.32M2.07M1.97M
Operating expense -12.42%13.54M32.49%16.9M13.62%50.97M3.13%10.54M-7.58%12.21M15.46M12.75M44.86M10.22M13.21M
Selling and administrative expenses -17.12%12.31M38.75%16.01M11.49%47.34M-5.99%10.01M-7.13%10.93M--14.86M--11.54M--42.46M--10.64M--11.77M
-Selling and marketing expense -29.82%6.69M35.18%10.73M0.50%30.68M-18.76%5.66M-13.55%7.55M--9.53M--7.94M--30.52M--6.97M--8.73M
-General and administrative expense 5.59%5.63M46.60%5.29M39.58%16.66M18.23%4.35M11.32%3.38M--5.33M--3.61M--11.94M--3.68M--3.04M
Research and development costs 102.81%1.23M-27.19%881K51.38%3.63M227.86%537K-11.27%1.28M--606K--1.21M--2.4M---420K--1.44M
Operating profit 19.53%-10.65M-25.57%-13.55M15.78%-39.73M10.86%-7.27M24.99%-8.43M-13.24M-10.79M-47.18M-8.16M-11.24M
Net non-operating interest income expense 58.58%-2.02M57.67%-1.96M-3.41%-15.89M58.07%-1.93M-3.64%-4.45M-4.88M-4.64M-15.37M-4.6M-4.29M
Non-operating interest income --0--1K-92.00%2K0.00%1K0.00%1K--0--0--25K--1K--1K
Non-operating interest expense -58.58%2.02M-57.65%1.97M3.25%15.9M-58.06%1.93M3.64%4.45M--4.88M--4.64M--15.39M--4.6M--4.29M
Other net income (expense) 1.98M642K-77.56%15.01M-62.43%4.9M-51.72%10.11M66.89M13.04M20.94M
Gain on sale of security --728K--642K-81.30%12.51M-62.43%4.9M-63.66%7.61M----------66.89M--13.04M--20.94M
Special income (charges) --1.25M------2.5M--0--2.5M--0------0--0--0
-Less:Other special charges ---1.25M-------2.5M--0---2.5M--------------------
Income before tax 40.97%-10.69M3.62%-14.87M-1,034.80%-40.62M-1,647.48%-4.3M-151.22%-2.77M-18.12M-15.43M4.35M278K5.41M
Income tax 0000000000
Net income 40.97%-10.69M3.62%-14.87M-1,034.80%-40.62M-1,647.48%-4.3M-151.22%-2.77M-18.12M-15.43M4.35M278K5.41M
Net income continuous Operations 40.97%-10.69M3.62%-14.87M-1,034.80%-40.62M-1,647.48%-4.3M-151.22%-2.77M---18.12M---15.43M--4.35M--278K--5.41M
Minority interest income
Net income attributable to the parent company 40.97%-10.69M3.62%-14.87M-1,034.80%-40.62M-1,647.48%-4.3M-151.22%-2.77M-18.12M-15.43M4.35M278K5.41M
Preferred stock dividends
Other preferred stock dividends 00-102.81%-412K3.8M3.94M14.68M
Net income attributable to common stockholders 51.20%-10.69M23.22%-14.87M-288.94%-40.21M72.99%-3.89M-151.22%-2.77M-21.91M-19.37M-10.34M-14.4M5.41M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg